XML 50 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Pulp And Tissue Restructuring
12 Months Ended
Dec. 31, 2011
Restructuring and Related Activities [Abstract]  
Pulp And Tissue Restructuring
Pulp and Tissue Restructuring
On January 21, 2011, we initiated a pulp and tissue restructuring plan in order to exit our remaining integrated pulp manufacturing operations and improve the underlying profitability and return on invested capital of our consumer tissue and K‑C Professional ("KCP") businesses. The restructuring involves the streamlining, sale or closure of six of our manufacturing facilities around the world. In conjunction with these actions, we have begun to exit certain non-strategic products, primarily non-branded offerings, and transfer some production to lower-cost facilities in order to improve overall profitability and returns. Facilities impacted by the restructuring include a facility in Everett, Washington, two facilities in Australia and two facilities in Spain.

In addition, on January 24, 2012, we announced our decision to streamline an additional manufacturing facility in North America to further enhance the profitability of our consumer tissue business. Estimated charges related to this additional restructuring action are expected to range from $30 million to $50 million before tax. 

Both restructuring actions are expected to be substantially completed by December 31, 2012.  The restructuring actions are expected to result in cumulative charges in 2011 and 2012 of approximately $550 million to $600 million before tax ($385 million to $420 million after tax).  Cash costs related to the streamlining of operations, sale or closure, relocation of equipment, severance and other expenses are expected to account for approximately 30 to 40 percent of the total charges. 
The following charges were incurred in connection with the restructuring: 
 
Year Ended December 31, 2011
 
(Millions of dollars)
Incremental depreciation
$
252

Charges for workforce reductions
71

Asset impairments
58

Asset write-offs
19

Other exit costs
7

Cost of products sold
407

Charges for workforce reductions included in Marketing, research and general expenses
6

Other exit costs included in Other (income) and expense, net
2

Provision for income taxes
(126
)
Net charges
$
289


See Note 18 for additional information on the pulp and tissue restructuring charges by segment.
Pretax charges for the pulp and tissue restructuring relate to activities in the following geographic areas:
 
Year Ended December 31, 2011
 
North
America
 
Australia
 
Other
 
Total
 
(Millions of dollars)
Incremental depreciation
$
165

 
$
73

 
$
14

 
$
252

Charges for workforce reductions
27

 
47

 
3

 
77

Asset impairments
—

 
—

 
58

 
58

Asset write-offs
10

 
9

 
—

 
19

Other exit costs
2

 
4

 
3

 
9

Total charges
$
204

 
$
133

 
$
78

 
$
415


The following summarizes the cash charges recorded and reconciles these charges to accrued expenses:
 
Year Ended December 31, 2011
 
(Millions of dollars)
Accrued expenses - January 1, 2011
$
—

Charges for workforce reductions and other exit costs
86

Cash payments
(51
)
Currency and other
2

Accrued expenses - December 31, 2011
$
37